Acute Lymphoblastic Leukemia Registry at Asan Medical Center
Prospective Observational Cohort Registry for Patients With Acute Lymphoblastic Leukemia at Asan Medical Center
Sponsor: Asan Medical Center
Terminated
The PI resigned the institute, and the rest investigators at the institute decided to terminate the study.
Other terminated trials from Asan Medical Center
Other Leukemia, Acute Lymphoblastic trials with similar outcome
A observational or N/A phase clinical study on Leukemia, Acute Lymphoblastic and Leukemia, Biphenotypic, Acute, this trial is terminated or withdrawn. The trial is conducted by Asan Medical Center and has accumulated 13 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated
-
Aug 2018 — Nov 2020 [monthly]
Terminated
-
Jun 2018 — Aug 2018 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
-
Apr 2018 — May 2018 [monthly]
Terminated
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Terminated NA
-
Aug 2017 — Jan 2018 [monthly]
Terminated NA
-
Jan 2017 — Aug 2017 [monthly]
Terminated NA
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Asan Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .